OOIR: Observatory of International Research

Papers

(The H4-Index of International Journal of Drug Policy is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Tackling the overdose crisis: The role of safe supply	125
Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019”	101
Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada	89
Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update	77
Safer opioid distribution in response to the COVID-19 pandemic	75
COVID-19 and the health of people who use drugs: What is and what could be?	70
Syringe services program (SSP) operational changes during the COVID-19 global outbreak	69
A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System	67
An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods	66
Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: A case study of the rural risk environment in Appalachian Kentucky	65
Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?	64
“You are not clean until you're not on anything”: Perceptions of medication-assisted treatment in rural Appalachia	59
The impact of COVID-19 restrictions on needle and syringe programme provision and coverage in England	59
Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19	56
Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences	54
Access to cannabidiol without a prescription: A cross-country comparison and analysis	50
Communicating THC levels and ‘dose’ to consumers: Implications for product labelling and packaging of cannabis products in regulated markets	50
Changes in characteristics of drug overdose death trends during the COVID-19 pandemic	49
I don't even want to go to the doctor when I get sick now: Healthcare experiences and discrimination reported by people who use drugs, Arizona 2019	49
Multi-level drivers of tobacco use and purchasing behaviors during COVID-19 “lockdown”: A qualitative study in the United States	47
A rapid review of the impacts of “Big Events ” on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19	47
COVID-19 - Enacting a ‘new normal’ for people who use drugs	46
From the clinic to the street: the changing role of benzodiazepines in the Scottish overdose epidemic	46
Care during COVID-19: Drug use, harm reduction, and intimacy during a global pandemic	44
Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis	44

Selectivity and sensitivity of urine fentanyl test strips to detect fentanyl analogues in illicit drugs	43
A narrative systematic review of sexualised drug use and sexual health outcomes among LGBT people	43
Doing ontopolitically-oriented research: Synthesising concepts from the ontological turn for alcohol and other drug research and other social sciences	43
“That's why people don't call 911”: Ending routine police attendance at drug overdoses	41
Intersectional structural vulnerability to abusive policing among people who inject drugs: A mixed methods assessment in California's central valley	41
Pathways between COVID-19 public health responses and increasing overdose risks: A rapid review and conceptual framework	40
Agency in the fentanyl era: Exploring the utility of fentanyl test strips in an opaque drug market	40
Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs	40
Addressing co-occurring public health emergencies: The importance of naloxone distribution in the era of COVID-19	38
Evaluation of fentanyl test strip distribution in two Mid-Atlantic syringe services programs	38
Intentions, actions and outcomes: A follow up survey on harm reduction practices after using an English festival drug checking service	38
“How will I get my next week's script?” Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic	37